STOCK TITAN

[Form 4] Neuraxis, Inc. Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4

Neuraxis, Inc. (NRXS) reporting person Timothy Robert Henrichs received restricted stock unit (RSU) awards as compensation and hiring/bonus grants totaling 242,017 RSUs across four grants. The reported grant dates are 01/03/2025, 03/04/2025 and 03/18/2025. Each grant is described as vesting in full at the end of 36 months. The awards convert into an equal number of common shares upon vesting: 8,037; 100,000; 66,000; and 67,980 shares respectively. The Form 4 lists per-share figures of $2.43 for the 03/18/2025 and 01/03/2025 grants and $2.18 for the 03/04/2025 grant, and indicates these RSUs were granted as compensation for services as an independent director, a hiring grant, a bonus, and under the Long-Term Incentive Plan. The filing is signed by the reporting person on 09/10/2025.

Timothy Robert Henrichs, persona che segnala per Neuraxis, Inc. (NRXS), ha ricevuto premi in unità di azioni vincolate (RSU) come compenso e come assegnazioni per assunzione/bonus per un totale di 242.017 RSU distribuite su quattro concessioni. Le date riportate delle concessioni sono 03/01/2025, 04/03/2025 e 18/03/2025. Ogni concessione è indicata come totalmente acquisita al termine di 36 mesi. Le RSU si convertono in un numero corrispondente di azioni ordinarie al momento dell'acquisizione: rispettivamente 8.037; 100.000; 66.000; e 67.980 azioni. Il Modulo 4 riporta valori per azione di $2,43 per le concessioni del 18/03/2025 e del 03/01/2025 e di $2,18 per la concessione del 04/03/2025, e indica che queste RSU sono state assegnate come compenso per servizi come amministratore indipendente, come incentivo di assunzione, come bonus e ai sensi del Piano di Incentivo a Lungo Termine. La dichiarazione è firmata dalla persona che segnala in data 10/09/2025.

Timothy Robert Henrichs, persona informante de Neuraxis, Inc. (NRXS), recibió premios en unidades de acciones restringidas (RSU) como compensación y concesiones por contratación/bono por un total de 242.017 RSU repartidas en cuatro otorgamientos. Las fechas informadas de los otorgamientos son 03/01/2025, 04/03/2025 y 18/03/2025. Cada otorgamiento figura con adquisición total al cabo de 36 meses. Las RSU se convertirán en un número igual de acciones ordinarias al consolidarse: 8.037; 100.000; 66.000; y 67.980 acciones, respectivamente. El Formulario 4 muestra precios por acción de $2,43 para los otorgamientos del 18/03/2025 y del 03/01/2025 y de $2,18 para el otorgamiento del 04/03/2025, e indica que estas RSU se concedieron como compensación por servicios como director independiente, como premio de contratación, como bono y bajo el Plan de Incentivos a Largo Plazo. La presentación está firmada por la persona informante el 10/09/2025.

신고인 티모시 로버트 헨리크스(Timothy Robert Henrichs)는 Neuraxis, Inc.(NRXS)로부터 보상 및 채용/보너스 지급으로 제한주식단위(RSU)를 총 242,017 RSU 수령했습니다. 신고된 부여일은 2025-01-03, 2025-03-04, 2025-03-18입니다. 각 부여는 36개월 종료 시 전부 베스팅되는 것으로 명시되어 있습니다. 해당 RSU들은 베스팅 시 각각 동일 수의 보통주로 전환됩니다: 8,037주; 100,000주; 66,000주; 및 67,980주. Form 4에는 03/18/2025 및 01/03/2025 부여의 주당 가액이 $2.43, 03/04/2025 부여의 주당 가액이 $2.18로 기재되어 있으며, 이 RSU들은 독립 이사로서의 서비스 보수, 채용 보상, 보너스 및 장기 인센티브 계획에 따라 부여된 것임을 나타냅니다. 신고서는 신고인이 2025-09-10에 서명했습니다.

La personne déclarant, Timothy Robert Henrichs, a reçu pour Neuraxis, Inc. (NRXS) des attributions d'unités d'actions restreintes (RSU) en tant que rémunération et en tant qu'attributions d'embauche/prime totalisant 242 017 RSU réparties sur quatre attributions. Les dates d'attribution déclarées sont le 03/01/2025, le 04/03/2025 et le 18/03/2025. Chaque attribution est indiquée comme entièrement acquise au terme de 36 mois. Les RSU se convertiront en un nombre égal d'actions ordinaires lors de l'acquisition : 8 037 ; 100 000 ; 66 000 ; et 67 980 actions respectivement. Le formulaire 4 indique des montants par action de 2,43 $ pour les attributions du 18/03/2025 et du 03/01/2025 et de 2,18 $ pour l'attribution du 04/03/2025, et précise que ces RSU ont été accordées en rémunération pour des services en tant qu'administrateur indépendant, comme prime d'embauche, comme bonus et dans le cadre du Plan d'incitation à long terme. Le dépôt est signé par la personne déclarant le 10/09/2025.

Die meldepflichtige Person Timothy Robert Henrichs erhielt bei Neuraxis, Inc. (NRXS) Restricted Stock Units (RSUs) als Vergütung sowie als Einstellungs-/Bonuszuteilungen in Höhe von insgesamt 242.017 RSUs auf vier Zuteilungen. Die gemeldeten Zuteilungsdaten sind 03.01.2025, 04.03.2025 und 18.03.2025. Jede Zuteilung ist als vollständig vestend nach 36 Monaten angegeben. Die Awards wandeln sich beim Vesting in dieselbe Anzahl Stammaktien um: jeweils 8.037; 100.000; 66.000; und 67.980 Aktien. Im Formular 4 werden pro Aktie $2,43 für die Zuteilungen vom 18.03.2025 und 03.01.2025 sowie $2,18 für die Zuteilung vom 04.03.2025 angegeben; ferner wird vermerkt, dass diese RSUs als Vergütung für Tätigkeiten als unabhängiges Mitglied des Vorstands, als Einstellungszuteilung, als Bonus und im Rahmen des Long-Term-Incentive-Plans gewährt wurden. Die Meldung ist vom Melder am 10.09.2025 unterschrieben.

Positive
  • Clear disclosure of four RSU grants with dates, amounts, and vesting terms
  • Total of 242,017 RSUs granted, each described with the specific plan or purpose (independent director compensation, hiring grant, bonus, LTIP)
  • Uniform 36‑month vesting creates a retention mechanism aligning the reporting person’s interests with longer‑term shareholder value
Negative
  • None.

Insights

TL;DR: Executive received time‑based RSU awards totaling 242,017 shares, vesting over 36 months, indicating compensation alignment with long‑term performance.

The Form 4 shows four RSU grants to Timothy Henrichs totaling 242,017 RSUs that convert to common stock upon vesting. Grant dates span January through March 2025 with listed per‑share reference amounts of $2.43 and $2.18. All awards vest in full after 36 months, creating a multi‑year retention schedule. For modeling, treat these as potential share issuance over the vesting horizon rather than immediate dilution because they are time‑based and contingent on continued service. The filing provides clear terms on vesting period and classifications (hiring grant, bonus, independent director compensation, LTIP).

TL;DR: Grants are routine time‑based RSUs with standard 36‑month vesting; disclosure is clear and complies with Section 16 reporting.

The disclosure identifies Henrichs as CFO and an independent director for the purposes of certain RSUs and documents four separate RSU awards with explicit vesting periods and share amounts. The Form 4 cites the nature of each award (director compensation, hiring, bonus, Long‑Term Incentive Plan) and includes the reporting signature dated 09/10/2025. From a governance perspective, these awards follow common practice of multi‑year vesting to align management/director incentives with shareholder interests. The filing does not state performance conditions—only time‑based vesting is described.

Timothy Robert Henrichs, persona che segnala per Neuraxis, Inc. (NRXS), ha ricevuto premi in unità di azioni vincolate (RSU) come compenso e come assegnazioni per assunzione/bonus per un totale di 242.017 RSU distribuite su quattro concessioni. Le date riportate delle concessioni sono 03/01/2025, 04/03/2025 e 18/03/2025. Ogni concessione è indicata come totalmente acquisita al termine di 36 mesi. Le RSU si convertono in un numero corrispondente di azioni ordinarie al momento dell'acquisizione: rispettivamente 8.037; 100.000; 66.000; e 67.980 azioni. Il Modulo 4 riporta valori per azione di $2,43 per le concessioni del 18/03/2025 e del 03/01/2025 e di $2,18 per la concessione del 04/03/2025, e indica che queste RSU sono state assegnate come compenso per servizi come amministratore indipendente, come incentivo di assunzione, come bonus e ai sensi del Piano di Incentivo a Lungo Termine. La dichiarazione è firmata dalla persona che segnala in data 10/09/2025.

Timothy Robert Henrichs, persona informante de Neuraxis, Inc. (NRXS), recibió premios en unidades de acciones restringidas (RSU) como compensación y concesiones por contratación/bono por un total de 242.017 RSU repartidas en cuatro otorgamientos. Las fechas informadas de los otorgamientos son 03/01/2025, 04/03/2025 y 18/03/2025. Cada otorgamiento figura con adquisición total al cabo de 36 meses. Las RSU se convertirán en un número igual de acciones ordinarias al consolidarse: 8.037; 100.000; 66.000; y 67.980 acciones, respectivamente. El Formulario 4 muestra precios por acción de $2,43 para los otorgamientos del 18/03/2025 y del 03/01/2025 y de $2,18 para el otorgamiento del 04/03/2025, e indica que estas RSU se concedieron como compensación por servicios como director independiente, como premio de contratación, como bono y bajo el Plan de Incentivos a Largo Plazo. La presentación está firmada por la persona informante el 10/09/2025.

신고인 티모시 로버트 헨리크스(Timothy Robert Henrichs)는 Neuraxis, Inc.(NRXS)로부터 보상 및 채용/보너스 지급으로 제한주식단위(RSU)를 총 242,017 RSU 수령했습니다. 신고된 부여일은 2025-01-03, 2025-03-04, 2025-03-18입니다. 각 부여는 36개월 종료 시 전부 베스팅되는 것으로 명시되어 있습니다. 해당 RSU들은 베스팅 시 각각 동일 수의 보통주로 전환됩니다: 8,037주; 100,000주; 66,000주; 및 67,980주. Form 4에는 03/18/2025 및 01/03/2025 부여의 주당 가액이 $2.43, 03/04/2025 부여의 주당 가액이 $2.18로 기재되어 있으며, 이 RSU들은 독립 이사로서의 서비스 보수, 채용 보상, 보너스 및 장기 인센티브 계획에 따라 부여된 것임을 나타냅니다. 신고서는 신고인이 2025-09-10에 서명했습니다.

La personne déclarant, Timothy Robert Henrichs, a reçu pour Neuraxis, Inc. (NRXS) des attributions d'unités d'actions restreintes (RSU) en tant que rémunération et en tant qu'attributions d'embauche/prime totalisant 242 017 RSU réparties sur quatre attributions. Les dates d'attribution déclarées sont le 03/01/2025, le 04/03/2025 et le 18/03/2025. Chaque attribution est indiquée comme entièrement acquise au terme de 36 mois. Les RSU se convertiront en un nombre égal d'actions ordinaires lors de l'acquisition : 8 037 ; 100 000 ; 66 000 ; et 67 980 actions respectivement. Le formulaire 4 indique des montants par action de 2,43 $ pour les attributions du 18/03/2025 et du 03/01/2025 et de 2,18 $ pour l'attribution du 04/03/2025, et précise que ces RSU ont été accordées en rémunération pour des services en tant qu'administrateur indépendant, comme prime d'embauche, comme bonus et dans le cadre du Plan d'incitation à long terme. Le dépôt est signé par la personne déclarant le 10/09/2025.

Die meldepflichtige Person Timothy Robert Henrichs erhielt bei Neuraxis, Inc. (NRXS) Restricted Stock Units (RSUs) als Vergütung sowie als Einstellungs-/Bonuszuteilungen in Höhe von insgesamt 242.017 RSUs auf vier Zuteilungen. Die gemeldeten Zuteilungsdaten sind 03.01.2025, 04.03.2025 und 18.03.2025. Jede Zuteilung ist als vollständig vestend nach 36 Monaten angegeben. Die Awards wandeln sich beim Vesting in dieselbe Anzahl Stammaktien um: jeweils 8.037; 100.000; 66.000; und 67.980 Aktien. Im Formular 4 werden pro Aktie $2,43 für die Zuteilungen vom 18.03.2025 und 03.01.2025 sowie $2,18 für die Zuteilung vom 04.03.2025 angegeben; ferner wird vermerkt, dass diese RSUs als Vergütung für Tätigkeiten als unabhängiges Mitglied des Vorstands, als Einstellungszuteilung, als Bonus und im Rahmen des Long-Term-Incentive-Plans gewährt wurden. Die Meldung ist vom Melder am 10.09.2025 unterschrieben.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Henrichs Timothy Robert

(Last) (First) (Middle)
11611 N. MERIDIAN ST, SUITE 330

(Street)
CARMEL IN 46032

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Neuraxis, INC [ NRXS ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Chief Financial Officer
3. Date of Earliest Transaction (Month/Day/Year)
01/03/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
RSU (1) 03/18/2025 A 8,037 (1) (1) Common Stock 8,037 $2.43 8,037 D
RSU (2) 03/18/2025 A 100,000 (2) (2) Common Stock 100,000 $2.43 100,000 D
RSU (3) 03/04/2025 A 66,000 (3) (3) Common Stock 66,000 $2.18 66,000 D
RSU (4) 01/03/2025 A 67,980 (4) (4) Common Stock 67,980 $2.42 67,980 D
Explanation of Responses:
1. These shares of common stock are restricted stock units (RSUs) granted to the reporting person as compensation for services as independent director of the Issuer. The RSUs will vest in full at the end of 36 months.
2. These shares of common stock are RSUs granted to the reporting person as the hiring grant. The RSUs will vest in full at the end of 36 months
3. These shares of common stock are RSUs granted to the reporting person as bonus under Neuraxis, Inc. 2022 Omnibus Securities and Incentive Plan, as amended. The RSUs will vest in full at the end of 36 months.
4. These shares of common stock are RSUs granted to the reporting person under the Long-Term Incentive Plan. The RSUs will vest in full at the end of 36 months.
/s/ Timothy Henrichs 09/10/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What RSU grants did Neuraxis (NRXS) reporting person Timothy Henrichs receive?

He received four RSU awards totaling 242,017 RSUs: 8,037, 100,000, 66,000, and 67,980 shares.

When do the RSU awards to Timothy Henrichs vest?

Each award is stated to vest in full at the end of 36 months from grant as described in the Form 4 explanations.

What are the grant dates and per‑share reference amounts listed on the Form 4?

Grant dates include 01/03/2025, 03/04/2025, and 03/18/2025. Per‑share figures listed are $2.43 for the 03/18/2025 and 01/03/2025 grants and $2.18 for the 03/04/2025 grant.

What roles does the Form 4 list for Timothy Henrichs at Neuraxis?

The Form 4 indicates he is an Officer (Chief Financial Officer) and an independent director per the award explanations.

When was the Form 4 signed by the reporting person?

The form shows the signature date as 09/10/2025.
Neuraxis Inc

NYSE:NRXS

NRXS Rankings

NRXS Latest News

NRXS Latest SEC Filings

NRXS Stock Data

24.09M
7.56M
20.42%
8.57%
0.3%
Biotechnology
Electromedical & Electrotherapeutic Apparatus
Link
United States
CARMEL